Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237079 · ClinicalTrials.gov registry record · Phase 4
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
A Phase 4 study, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT02237079: Completed Phase 4 study, sponsored by Tulane University Health Sciences Center.
NCT02237079 is a Phase 4 study that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 17 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02237079, a Phase 4 study, has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this pilot clinical study is to perform a randomized placebo-controlled study to assess the beneficial effect of a 3 month-treatment with Bazedoxifene/Conjugated Estrogens (BZA/CE) vs. placebo on glucose homeostasis and body composition in 20 post-menopausal women. The recruitment will be performed at Tulane Health Sciences Center.
Primary Outcome
Body composition will be assessed through change in body mass index at baseline and at 3 months post-treatment.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Bazedoxifene/Conjugated Estrogens (BZA/CE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-04 |
| Phase | Phase 4 |
What the finished NCT02237079 record still lists
NCT02237079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT02237079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02237079 about?
NCT02237079 is a clinical study titled "Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)". The goal of this pilot clinical study is to perform a randomized placebo-controlled study to assess the beneficial effect of a 3 month-treatment with Bazedoxifene/Conjugated Estrogens (BZA/CE) vs. placebo on glucose homeostasis and body composition in 20 post-menopausal women. The recruitment will b...
What is the current status of trial NCT02237079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2014-12. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02237079?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Bazedoxifene/Conjugated Estrogens (BZA/CE) (DRUG).
Who is sponsoring clinical trial NCT02237079?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02237079's enrollment target sits among peer trials
17 1854th of 2000 higher than 132 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia